Long-term clinical outcomes after placement of an implantable cardioverter-defibrillator: does the etiology of heart failure matter?

heart failure implantable cardioverter-defibrillators ischemic heart disease nonischemic cardiomyopathy prognostic factor

Journal

Kardiologia polska
ISSN: 1897-4279
Titre abrégé: Kardiol Pol
Pays: Poland
ID NLM: 0376352

Informations de publication

Date de publication:
24 04 2020
Historique:
pubmed: 24 3 2020
medline: 28 4 2021
entrez: 24 3 2020
Statut: ppublish

Résumé

European and American guidelines for the placement of implantable cardioverter‑defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT‑D) in patients with heart failure (HF) remain unchanged despite controversy and ongoing debate on the etiology of HF. However, there are limited data on the long‑term follow‑up in patients who received primary defibrillator therapy with regard to ischemic cardiomyopathy (ICM) and nonischemic cardiomyopathy (NICM). The prognostic significance of the etiology of HF is not well established. The aim of the study was to assess the predictive value of the cause of HF. A total of 1073 patients with the first implantation of ICD/CRT‑D between January 2009 and December 2013 from the COMMIT‑HF (Contemporary Modalities In Treatment of Heart Failure) registry were selected for the study. Patients were divided into 2 groups depending on the etiology of HF: ischemic (n = 705; 65.7%) and nonischemic (n = 368; 34.3%). The primary endpoint was long‑term all‑cause mortality. The median follow‑up was 60.5 months. The primary endpoint occurred more often in the ICM as compared with the NICM group (35.7% vs 26.6%; P = 0.008). A higher out‑of‑hospital mortality in patients with ICM tended to be statistically significant (15.5% vs 10.6; P = 0.05). The multivariate analysis revealed that, among others, an ischemic etiology of HF was an independent factor of long‑term mortality (hazard ratio, 1.43; 95% CI, 1.30-1.81; P = 0.003). Other independent predictors for mortality are: age older than 65 years, impaired left ventricular ejection fraction, chronic kidney disease, atrial fibrillation, diabetes mellitus. In the real‑world population, significantly worse survival of patients with ICM in comparison with those with NICM is observed, and an ischemic etiology of HF is a strong independent predictor of mortality among individuals following the placement of ICD/ CRT‑D.

Sections du résumé

BACKGROUND
European and American guidelines for the placement of implantable cardioverter‑defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT‑D) in patients with heart failure (HF) remain unchanged despite controversy and ongoing debate on the etiology of HF. However, there are limited data on the long‑term follow‑up in patients who received primary defibrillator therapy with regard to ischemic cardiomyopathy (ICM) and nonischemic cardiomyopathy (NICM). The prognostic significance of the etiology of HF is not well established.
AIMS
The aim of the study was to assess the predictive value of the cause of HF.
METHODS
A total of 1073 patients with the first implantation of ICD/CRT‑D between January 2009 and December 2013 from the COMMIT‑HF (Contemporary Modalities In Treatment of Heart Failure) registry were selected for the study. Patients were divided into 2 groups depending on the etiology of HF: ischemic (n = 705; 65.7%) and nonischemic (n = 368; 34.3%). The primary endpoint was long‑term all‑cause mortality.
RESULTS
The median follow‑up was 60.5 months. The primary endpoint occurred more often in the ICM as compared with the NICM group (35.7% vs 26.6%; P = 0.008). A higher out‑of‑hospital mortality in patients with ICM tended to be statistically significant (15.5% vs 10.6; P = 0.05). The multivariate analysis revealed that, among others, an ischemic etiology of HF was an independent factor of long‑term mortality (hazard ratio, 1.43; 95% CI, 1.30-1.81; P = 0.003). Other independent predictors for mortality are: age older than 65 years, impaired left ventricular ejection fraction, chronic kidney disease, atrial fibrillation, diabetes mellitus.
CONCLUSIONS
In the real‑world population, significantly worse survival of patients with ICM in comparison with those with NICM is observed, and an ischemic etiology of HF is a strong independent predictor of mortality among individuals following the placement of ICD/ CRT‑D.

Identifiants

pubmed: 32200617
doi: 10.33963/KP.15242
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

318-324

Auteurs

Michał Wasiak (M)

Department of Cardiology, Central Clinical Hospital of the Ministry of the Interior and Administration, Warsaw, Poland; 3rd Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland. wasiakmichal999@gmail.com

Mateusz Tajstra (M)

3rd Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland

Łukasz Pyka (Ł)

3rd Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland

Mariusz Gąsior (M)

3rd Department of Cardiology, Silesian Centre for Heart Diseases, Medical University of Silesia, Zabrze, Poland

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH